首页> 外国专利> IMPROVING OR PREVENTING AGENT FOR CHRONIC TRANSPLANTED LUNG DYSFUNCTION

IMPROVING OR PREVENTING AGENT FOR CHRONIC TRANSPLANTED LUNG DYSFUNCTION

机译:改善或预防慢性移植肺功能障碍的药物

摘要

To provide immunosuppressive agents that can prolong rejection suppression after lung transplantation.SOLUTION: According to the present invention, the agent for improving or preventing chronic transplanted lung dysfunction containing MEK inhibitor as an active ingredient can prolong the suppression of rejection after lung transplantation, and enables chronic transplanted lung dysfunction (CLAD) to be improved or prevented. An agent for improving or preventing chronic transplanted lung dysfunction containing an MEK inhibitor as an active ingredient is administered to a lung transplanted patient who has been treated for acute immune rejection.SELECTED DRAWING: None
机译:提供能够延长肺移植后排斥反应抑制的免疫抑制剂。解决方案:根据本发明,以MEK抑制剂为有效成分的用于改善或预防慢性移植肺功能障碍的药物可以延长肺移植后排斥反应的抑制,并能够慢性移植性肺功能障碍(CLAD)有待改善或预防。将含有MEK抑制剂作为有效成分的改善或预防慢性移植肺功能障碍的药物施用于已接受急性免疫排斥反应治疗的肺移植患者。

著录项

  • 公开/公告号JP2019142795A

    专利类型

  • 公开/公告日2019-08-29

    原文格式PDF

  • 申请/专利权人 KYOTO UNIV;

    申请/专利号JP20180027063

  • 申请日2018-02-19

  • 分类号A61K45;A61K31/4523;A61P11;A61P37/06;A61P43;A61K31/519;

  • 国家 JP

  • 入库时间 2022-08-21 12:23:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号